CJC-1295 No DAC

CJC-1295 without DAC (also known as Modified GRF 1-29) is a truncated analogue of Growth Hormone-Releasing Hormone (GHRH), originally developed in the 1980s. This peptide is widely studied in the field of endocrinology and metabolic science due to its shorter half-life and targeted GH pulse stimulation.
Researchers are exploring CJC-1295 No DAC for its potential to:
Support muscle growth pathways
Improve wound healing processes
Enhance metabolic function
Promote bone strength and density
Regulate blood sugar levels
Unlike the DAC (Drug Affinity Complex) version, CJC-1295 without DAC allows more controlled and natural pulsatile release of growth hormone during in vitro experimentation, making it a preferred compound in many scientific studies.